Exosomes from CIITA-Transfected CT26 Cells Enhance Anti-tumor Effects |
Fan, Wen
(First Affiliated Hospital of Yangtze University)
Tian, Xing-De (First Affiliated Hospital of Yangtze University) Huang, E. (First Affiliated Hospital of Yangtze University) Zhang, Jia-Jun (First Affiliated Hospital of Yangtze University) |
1 | Martin-Jaular L, Nakayasu ES, Ferrer M, et al (2011). Exosomes from Plasmodium yoelii-infected reticulocytes protect mice from lethal infections. PLoS One, 6, e26588. DOI |
2 | Mathias RA, Lim JW, Ji H, et al (2009). Isolation of extracellular membranous vesicles for proteomic analysis. Methods Mol Biol, 528, 227-42. DOI ScienceOn |
3 | Morse MA, Secord AA, Blackwell K, et al (2011). MHC class I-presented tumor antigens identified in ovarian cancer by immunoprot-eomic analysisare targets for T-cell responses against breast and ovarian cancer. Clin Cancer Res, 17, 3408-19. DOI |
4 | Mortara L, Castellani P, Meazza R, et al (2006). CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory. Clin Cancer Res, 12, 3435-43. DOI ScienceOn |
5 | Nazarenko I, Rana S, Baumann A, et al (2010). Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res, 70, 1668-78. DOI |
6 | Rountree RB, Mandl SJ, Nachtwey JM, et al (2011). Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy. Cancer Res, 71, 5235-44. DOI |
7 | Sartoris S, Brendolan A, Degola A, et al (2000). Analysis of CIITA encoding AIR-1 gene promoters in insulin-dependent diabetes mellitus and rheumatoid arthritis patients from the northeast of Italy: absence of sequence variability. Hum Immunol, 61, 599-604. DOI ScienceOn |
8 | Schnitzer JK, Berzel S, Fajardo-Moser M, et al (2010). Fragments of antigen-loaded dendritic cells (DC) and DC-derived exosomes induce protective immunity against Leishmania major. Vaccine, 28, 5785-93. DOI ScienceOn |
9 | Silva J, Garcia V, Rodriguez M, et al (2012). Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes Cancer, 51, 409-18. DOI ScienceOn |
10 | Southcombe J, Tannetta D, Redman C, et al (2011). The immunomodulatory role of syncytiotrophoblast microvesicles. PLoS One, 6, e20245. DOI |
11 | Tan A, De La Pena H, Seifalian AM (2010). The application of exosomes as a nanoscale cancer vaccine. Int J Nanomedicine, 5, 889-900. |
12 | van Niel G, Raposo G, Candalh C, et al (2001). Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology, 121, 337-49. DOI ScienceOn |
13 | Andre F, Chaput N, Schartz NE, et al (2004). Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J Immunol, 172, 2126-36. DOI |
14 | Verweij FJ, van Eijndhoven MA, Hopmans ES, et al (2011). LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF- activation. EMBO J, 30, 2115-29. DOI ScienceOn |
15 | Viaud S, Thery C, Ploix S, et al (2010). Dendritic cell-derived exosomes for cancer immunotherapy: what's next? Cancer Res, 70, 1281-5. DOI ScienceOn |
16 | Wiley RD, Gummuluru S (2006). Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc Natl Acad Sci USA, 103, 738-43. DOI ScienceOn |
17 | Bobrie A, Colombo M, Raposo G, et al (2011). Exosome secretion: molecular mechanisms and roles in immune responses. Traffic, 12, 1659-68. DOI ScienceOn |
18 | Caby MP, Lankar D, Vincendeau-Scherrer C, et al (2005). Exosomal-like vesicles are present in human blood plasma. Int Immunol, 17, 879-87. DOI ScienceOn |
19 | Chaput N, Thery C (2011). Exosomes: immune properties and potential clinical implementations. Semin Immunopathol, 33, 419-40. DOI ScienceOn |
20 | Cheng Y, Sanderson C, Jones M, et al (2012). Low MHC class II diversity in the Tasmanian devil (Sarcophilus harrisii). Immunogenetics, 64, 525-33. DOI ScienceOn |
21 | Cho JA, Lee YS, Kim SH, et al (2009). MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generatetumor regression in murine models. Cancer Lett, 275, 256-65. DOI ScienceOn |
22 | de Vrij J, Maas SL, Hegmans JP, et al (2011).[Exosomes and cancer]. Ned Tijdschr Geneeskd, 155, A3677. |
23 | Hao S, Yuan J, Xiang J (2007). Nonspecific T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CTL responses and long-term T cell memory. J Leukoc Biol, 82, 829-38. DOI ScienceOn |
24 | Filipazzi P, Burdek M, Villa A, et al (2012). Recent advances on the role of tumor exosomes in immunosuppression and disease progression. Semin Cancer Biol, 22, 342-9. DOI ScienceOn |
25 | Frangione V, Mortara L, Castellani P, et al (2010).CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor T lymphocytes for immunotherapy. Int J Cancer, 127, 1614-24. DOI ScienceOn |
26 | Gastpar R, Gehrmann M, Bausero MA, et al (2005). Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res, 65, 5238-47. DOI ScienceOn |
27 | Luketic L, Delanghe J, Sobol PT, et al (2007). Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL. J Immunol, 179, 5024-32. DOI |
28 | Lv LH, Wan YL, Lin Y, et al (2012).Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell anti-tumor responses in vitro. J Biol Chem, 287, 15874-85. DOI |